Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?

Author： Pullenayegum Eleanor M.   Tarride Jean-Eric   Xie Feng   Goeree Ron   Gerstein Hertzel C.   O'Reilly Daria  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.4, 2010-06, pp. : 487-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bayesian Analysis of Diagnostic Test Accuracy When Disease State is Unverified for Some Subjects

By Pennello Gene A.  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 5, 2011-09 ,pp. : 954-970

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Review of Health-Utility Data for Osteoarthritis: Implications for Clinical Trial-Based Evaluation

By Ruchlin Hirsch S.  

PharmacoEconomics, Vol. 26, Iss. 11, 2008-01 ,pp. : 925-935

Adis International

Access to resources Recommend Favorite

The Appropriate Elicitation of Expert Opinion in Economic Models: Making Expert Data Fit for Purpose

By Sullivan William  

PharmacoEconomics, Vol. 29, Iss. 6, 2011-06 ,pp. : 455-459

Adis International

Access to resources Recommend Favorite

When Are NSAIDs Appropriate in Osteoarthritis?

By Bird H.A.  

Drugs & Aging, Vol. 12, Iss. 2, 1998-02 ,pp. : 87-95

Adis International

Access to resources Recommend Favorite

QT/QTc Prolongation in Placebo-Treated Subjects: a PhRMA Collaborative Data Analysis

By Agin Marilyn  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 3, 2008-05 ,pp. : 408-426

Taylor & Francis Ltd

Access to resources Recommend Favorite